{"id":"W1964785646","doi":"10.1053/j.gastro.2005.06.064","title":"A Randomized, Placebo-Controlled Trial of Certolizumab Pegol (CDP870) for Treatment of Crohn’s Disease","year":2005,"lang":"en","type":"article","venue":"Gastroenterology","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":581,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Manitoba; Hôpital Saint-Luc; Dalhousie University; University of Alberta","funders":"","keywords":"Certolizumab pegol; Placebo; Medicine; Crohn's disease; Internal medicine; Gastroenterology; Clinical endpoint; Adverse effect; Clinical trial; Tumor necrosis factor alpha; Disease; Infliximab; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.002046607,0.001819597,0.005366568,0.0006318456,0.0007445085,0.001373737,0.001153098,0.002987473,0.009379374],"category_scores_gemma":[0.002869011,0.001170851,0.002160451,0.0004710637,0.002143183,0.001558479,0.0006861708,0.004013016,0.001530632],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009120982,"about_ca_system_score_gemma":0.001179759,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001363065,"about_ca_topic_score_gemma":0.002076721,"domain_scores_codex":[0.9988589,0.0006140606,0.00007814289,0.0001957316,0.00007118426,0.0001820262],"domain_scores_gemma":[0.998704,0.0004752627,0.0001948743,0.0001275669,0.00008465694,0.000413602],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.994285,0.001484231,0.0001044443,0.0002410024,0.0004350668,0.00002091304,0.00001360439,0.00005511244,0.0005697739,0.00004637889,0.0002062056,0.002538111],"study_design_scores_gemma":[0.9892897,0.009831602,0.0003351664,0.000009684148,0.0002048116,0.000009616669,0.000007339302,0.00006571261,0.00006871455,0.00004071097,0.0001326344,0.000004143211],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9775888,0.007742856,0.0009648619,0.001762128,0.002363842,0.004575556,0.001253344,0.0002051031,0.003543618],"genre_scores_gemma":[0.986886,0.002709072,0.001305689,0.001802089,0.0008024538,0.002616747,0.0009803174,0.00002907342,0.002868523],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.009379374,"threshold_uncertainty_score":0.0313772,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.008893918375164978,"score_gpt":0.2538233828180657,"score_spread":0.2449294644429007,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}